KHTRF News Alert Knight Therapeutics (KHTRF) 5.7128 09/21/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Knight Therapeutics (KHTRF) 5.7128 $KHTRF

Knight Therapeutics Inc. Acquires Orphan Canada Inc. and Expands Business Development Capacity
Marketwire - Tue Sep 02, 7:33AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into an asset purchase agreement with Orphan Canada Inc. ("Orphan" related to the Canadian rights for ATryn(R) and PHOTOFRIN(R) (porfimer sodium), two innovative pharmaceutical products approved for sale in multiple jurisdictions. Orphan is a privately-held, Toronto-based specialty pharmaceutical company that in-licenses therapies for rare disorders and specialty medicines for the Canadian market.

Knight Expands Team
Marketwire - Tue Aug 26, 7:04AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" announced today (1) the appointment of Amal Khouri to the position of Vice President of Business Development and (2) the appointment of Sylvie Tendler to Knight's Board of Directors. "Both Amal and Sylvie are proven pharmaceutical executives and expand our capacity to secure the rights to innovative pharmaceuticals that improve the health of Canadians", said Jonathan Ross Goodman, President and CEO of Knight.

Knight Reports Second Quarter 2014 Results
Marketwire - Thu Aug 14, 5:01AM CDT
Knight Therapeutics Inc. ("Knight" (TSX: GUD) today reported its financial results for the quarter ended June 30, 2014.

Knight Therapeutics Inc. Hires Advisor to Sell Its Priority Review Voucher
Marketwire - Tue Aug 12, 7:04AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into an arrangement with a global investment banking firm to sell its neglected tropical disease Priority Review Voucher ("PRV" . The arrangement is effective August 18, 2014.

Medicure Acquires Minority Position in Pharmaceutical Manufacturer, Apicore
Marketwire - Thu Jul 03, 7:38AM CDT
Medicure Inc. ("Medicure" or the "Company" (TSX VENTURE: MPH)(OTCQB: MCUJF), a specialty pharmaceutical company, today announced that the Company and its newly formed and wholly owned subsidiary, Medicure U.S.A. Inc. ("Medicure USA" have entered into an arrangement whereby they have acquired a minority interest in a pharmaceutical manufacturing business. Specifically, Medicure and Medicure USA have acquired a 6.09% equity interest (5.33% on a fully-diluted basis) (the "Ownership Interest" in two newly formed holding companies of which Apicore LLC and Apicore US LLC (collectively, "Apicore" will be wholly owned operating subsidiaries. Medicure also received an option to acquire all of the remaining issued shares of Apicore LLC and the holding company of Apicore US LLC, within the next 3 years. The Ownership Interest and certain other rights, including the Option Rights described below, were obtained by Medicure for its lead role in structuring a US$22.5 million, majority interest purchase and financing of Apicore (the "Purchase" by Signet Healthcare Partners ("Signet" , Knight Therapeutics Inc. (TSX: GUD) ("Knight" , and investors affiliated with Sanders Morris Harris Inc. ("Sanders" (collectively, the "Investors" .

Knight Therapeutics Inc. Signs Secured Debt Financing Agreement to Support the Acquisition of Apicore
Marketwire - Thu Jul 03, 7:21AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into a secured debt agreement to support the acquisition of two newly formed holding companies of which Apicore LLC and Apicore US LLC (collectively, "Apicore" will be wholly owned operating subsidiaries. The purchase arrangement included a secured loan provided by Knight and Sanders Morris Harris Inc., and an equity investment by Signet Healthcare Partners ("Signet" for an aggregate amount of US$22.5 million. Medicure Inc. ("Medicure" acquired a minority interest in Apicore and the founding shareholders of Apicore continue to own a significant minority interest in Apicore.

Knight Therapeutics Inc. Invests in Sectoral Asset Management Inc. for Preferred Access to Canadian Product Rights
Marketwire - Thu Jun 26, 7:03AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into a letter of agreement with Sectoral Asset Management Inc. ("Sectoral" to invest USD$13 million into its New Emerging Medical Opportunities Funds II, Ltd. ("NEMO II" .

Knight Therapeutics Inc. and Origin Biomed Inc. Sign Secured Debt Financing Agreement
Marketwire - Wed Jun 25, 8:32AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into a secured debt agreement with privately-held Origin Biomed Inc. ("Origin" , a company dedicated to the worldwide commercialization of the Neuragen(R) and Bionica brands.

Knight Therapeutics to Present at the Bloom Burton & Co. Healthcare Investor Conference in Toronto
Marketwire - Wed Jun 18, 1:29AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that Mr. Jonathan Ross Goodman, President & CEO, is scheduled to present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference on Wednesday June 18, 2014 at 11:30 am ET at the Toronto Board of Trade. A copy of the presentation will be available at www.gud-knight.com.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amcor's Q3 2026 Results Loom: What's at Stake?

Updated Category News Views 4

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

Continue Reading
Navigating Legal Advice Post-Car Crash: A Crucial Guide

Updated Category News Views 0

It's a simple blink-and-you-miss-it moment: one second you're cruising down the street, and the next you're in a fender bender. But if you think you can handle everything solo from here on out, think again. A HelloNation article featuring Pittsburgh attorney Frank Walker brings crucial clarity to when and why you might need a lawyer after a car crash. The Misleading Calm...

Continue Reading
Genimous Lands a Role as an OpenAI Select Partner

Updated Category News Views 4

Genimous Teaming Up with OpenAI Genimous just got the nod from OpenAI, bagging a spot as a Select Partner. Now, if you've been paying any attention, you know OpenAI isn’t handing out partnerships like Halloween candy. Genimous got this shiny badge due to its work in digital interaction marketing. We’re talking from gaming to e-commerce, they’ve got the hands in...

Continue Reading
InfraMed Expands Team for National Healthcare Growth

Updated Category News Views 3

InfraMed's Bold Move in Healthcare Real Estate You know, it’s not every day you see a company go all in on healthcare properties like InfraMed’s doing. With the blitz of new personnel, we're talking about a genuine push to carve out a piece of the national market. And if you've been keeping tabs, this isn't just a hunch—they've got serious momentum brewing, and the...

Continue Reading
FIBRA Prologis Posts Strong Q3 2026 Results Amid Market Trends

Updated Category News Views 5

Decoding FIBRA Prologis' Latest Numbers Never a dull moment in industrial real estate, folks—and FIBRA Prologis (BMV:FIBRAPL 14) just dropped its third quarter earnings results for 2026, lighting a fire in its trajectory. On the surface, their numbers seem to belt out a victory anthem, but let's peel back the layers to understand what truly hums under the hood. A...

Continue Reading
New American Perspectives Shines at HIFF 2026

Updated Category News Views 5

Ever notice how the arts can cut through the noise and spotlight voices we often overlook? Well, that's exactly what's happening at the Hawai?i International Film Festival (HIFF) this year. The Vilcek Foundation, alongside HIFF, is bringing the New American Perspectives program back for another round at the festival’s 46th edition, and it's a heck of a lineup....

Continue Reading
Selling Your Home? Key Fixes John Spear Recommends

Updated Category News Views 3

Cracking the Code of Real Estate in Cape Girardeau If you're about to stick that 'For Sale' sign in the lawn, listen up. Cape Girardeau's own real estate legend, John Spear—lovingly dubbed "Mr. Cape Girardeau" for good reason—is spilling the beans on what to spruce up before selling your humble abode. And spoiler alert: it's not about blowing a year's salary on a...

Continue Reading
Anrok Integrates AI for Seamless Tax Management Efficiency

Updated Category News Views 5

Streamlining Tax Management with AI Integration You know, managing tax data can be as thrilling as watching paint dry, but Anrok's latest move might just shake the dullness out of it. San Francisco's own Anrok has rolled out their Anrok MCP, a game-changer that's putting tax management into the fast lane. This isn't just about tossing out the old tax data headaches, it's...

Continue Reading
ESENTIA Sets Stage for Q3 2026 Earnings Insights

Updated Category News Views 4

A Snapshot of What's Coming You know the drill, folks—when the calendar flips close to earnings season, the scramble starts for details that make or break the quarter. ESENTIA Energy Development, the big dog in the Mexican natural gas scene, is poised to drop its third-quarter 2026 numbers right after the market bell sounds on October 28th. They've been flexing their...

Continue Reading
SportsMed Expands with Hoboken Clinic Opening

Updated Category News Views 6

SportsMed's Strategic Hoboken Leap The healthcare landscape in New Jersey and Connecticut's about to get a shake-up, and all eyes should be on SportsMed Physical Therapy. They've just planted their flag in Hoboken with a new clinic, bumping their operational presence up to a whopping 57 clinics. Quite the comeback story from their humble beginnings. Now, that's some...

Continue Reading

Top 5 Most Recently Viewed Articles

La Verde Strikes Big with New Copper-Gold Finds

Updated Category News Views 13

La Verde's Impressive Drill Results: A Deeper Dive When the earth gives up treasures richer than predicted, you know you've struck something special. La Verde, the emerging copper-gold sensation south of Costa Fuego, just did exactly that. Hot Chili Limited's recent diamond drill hole (DKD044) coughed up 391.1 meters grading at 0.51% copper equivalent (CuEq) straight from...

Continue Reading
Critical Metals Corp's Strategic Move with REalloys Inc. Partnership

Updated Category News Views 158

Critical Metals Corp Forms Strategic Pact with REalloys Inc. Critical Metals Corp (NASDAQ: CRML) has taken an important step in fortifying its position in the rare earths market by announcing a new off-take agreement with REalloys Inc. This partnership will see Critical Metals deliver up to 15% of its production from the Tanbreez Project, a significant development for...

Continue Reading
Empowering Families Through Mesothelioma Awareness Series

Updated Category News Views 164

Meso: The Mesothelioma Podcast Offers Vital Support Mesothelioma represents more than just a medical term; it is a profound challenge that can dramatically affect the lives of those diagnosed, along with their families and caregivers. In light of this, a new initiative has emerged aimed at lighting the path towards better understanding and coping mechanisms for those...

Continue Reading
Emeren Group Completes Sale of Renewable Energy Portfolio

Updated Category News Views 151

Emeren Group Completes Remarkable Sale of Solar Portfolio Emeren Group Ltd, known for its expertise in solar energy, has recently completed the sale of a notable 17 MW operational solar portfolio. This project, consisting of a solid 15 MW under a Power Purchase Agreement (PPA) and an additional 2 MW, was fully developed and constructed by the skilled team at Emeren. The...

Continue Reading
Understanding Market Dynamics Behind Boston Scientific's Options

Updated Category News Views 197

Boston Scientific's Market Overview Recent observations from key financial analysts indicate significant bearish activities surrounding Boston Scientific. Understanding the behavior of these market giants is crucial for investors. Our detailed analysis of Boston Scientific (NYSE: BSX) options activity shows notable patterns that investors should consider. Key Trading...

Continue Reading